ECB-ART-52111
Materials (Basel)
2022 Dec 19;1524:. doi: 10.3390/ma15249082.
Show Gene links
Show Anatomy links
Bioactive Glasses as Carriers of Cancer-Targeted Drugs: Challenges and Opportunities in Bone Cancer Treatment.
Borges R
,
Pelosine AM
,
de Souza ACS
,
Machado J
,
Justo GZ
,
Gamarra LF
,
Marchi J
.
???displayArticle.abstract???
The treatment of bone cancer involves tumor resection followed by bone reconstruction of the defect caused by the tumor using biomaterials. Additionally, post-surgery protocols cover chemotherapy, radiotherapy, or drug administration, which are employed as adjuvant treatments to prevent tumor recurrence. In this work, we reviewed new strategies for bone cancer treatment based on bioactive glasses as carriers of cancer-targeted and other drugs that are intended for bone regeneration in conjunction with adjuvant treatments. Drugs used in combination with bioactive glasses can be classified into cancer-target, osteoclast-target, and new therapies (such as gene delivery and bioinorganic). Microparticulated, nanoparticulated, or mesoporous bioactive glasses have been used as drug-delivery systems. Additionally, surface modification through functionalization or the production of composites based on polymers and hydrogels has been employed to improve drug-release kinetics. Overall, although different drugs and drug delivery systems have been developed, there is still room for new studies involving kinase inhibitors or antibody-conjugated drugs, as these drugs have been poorly explored in combination with bioactive glasses.
???displayArticle.pubmedLink??? 36556893
???displayArticle.link??? Materials (Basel)
???displayArticle.grants??? [+]
2016/16512-9; 2020/00329-6 São Paulo Research Foundation, 001, 002, 88887.468995/2019-00 Coordenação de Aperfeicoamento de Pessoal de Nível Superior
References [+] :
Aina,
Conjugation of amino-bioactive glasses with 5-aminofluorescein as probe molecule for the development of pH sensitive stimuli-responsive biomaterials.
2014, Pubmed
Aina, Conjugation of amino-bioactive glasses with 5-aminofluorescein as probe molecule for the development of pH sensitive stimuli-responsive biomaterials. 2014, Pubmed
Al-Bari, Current advances in regulation of bone homeostasis. 2020, Pubmed
Arnida, Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages. 2011, Pubmed
Baino, Biomedical Radioactive Glasses for Brachytherapy. 2021, Pubmed
Baish, Scaling rules for diffusive drug delivery in tumor and normal tissues. 2011, Pubmed
Banerjee, Antifouling coatings: recent developments in the design of surfaces that prevent fouling by proteins, bacteria, and marine organisms. 2011, Pubmed
Bentley, The evolution of thrombospondins and their ligand-binding activities. 2010, Pubmed
Bhullar, Kinase-targeted cancer therapies: progress, challenges and future directions. 2018, Pubmed
Boanini, Alendronate Functionalized Mesoporous Bioactive Glass Nanospheres. 2016, Pubmed
Bonnans, Remodelling the extracellular matrix in development and disease. 2014, Pubmed
Brault, Two-layer architecture using atom transfer radical polymerization for enhanced sensing and detection in complex media. 2012, Pubmed
Bros, The Protein Corona as a Confounding Variable of Nanoparticle-Mediated Targeted Vaccine Delivery. 2018, Pubmed
Brown, Integrin-associated protein (CD47) and its ligands. 2001, Pubmed
Cai, The Crown and the Scepter: Roles of the Protein Corona in Nanomedicine. 2019, Pubmed
Chen, Preparation and characterization of folic acid functionalized bioactive glass for targeted delivery and sustained release of methotrexate. 2019, Pubmed
Chew, Biomaterial-Based Implantable Devices for Cancer Therapy. 2017, Pubmed
Corazzari, Gallic acid grafting modulates the oxidative potential of ferrimagnetic bioactive glass-ceramic SC-45. 2016, Pubmed
Cox, Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer. 2011, Pubmed
Czarnobaj, Formulation and In Vitro Characterization of Bioactive Mesoporous Silica with Doxorubicin and Metronidazole Intended for Bone Treatment and Regeneration. 2017, Pubmed
Dai, Quantifying the Ligand-Coated Nanoparticle Delivery to Cancer Cells in Solid Tumors. 2018, Pubmed
Danewalia, Bioactive glasses and glass-ceramics for hyperthermia treatment of cancer: state-of-art, challenges, and future perspectives. 2021, Pubmed
Delpino, Sol-gel-derived 58S bioactive glass containing holmium aiming brachytherapy applications: A dissolution, bioactivity, and cytotoxicity study. 2021, Pubmed
Dhillon, Moxetumomab Pasudotox: First Global Approval. 2018, Pubmed
Dimou, Overcoming the stromal barrier: technologies to optimize drug delivery in pancreatic cancer. 2012, Pubmed
Dosio, Immunotoxins and anticancer drug conjugate assemblies: the role of the linkage between components. 2011, Pubmed
Drake, Bisphosphonates: mechanism of action and role in clinical practice. 2008, Pubmed
Ebert, Probenecid as a sensitizer of bisphosphonate-mediated effects in breast cancer cells. 2014, Pubmed
Ebied, New Drugs Approved in 2021. 2022, Pubmed
Ege, Borate Bioactive Glasses (BBG): Bone Regeneration, Wound Healing Applications, and Future Directions. 2022, Pubmed
Eliaz, Calcium Phosphate Bioceramics: A Review of Their History, Structure, Properties, Coating Technologies and Biomedical Applications. 2017, Pubmed
Ernsting, Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles. 2013, Pubmed
Falzone, Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium. 2018, Pubmed
Fang, The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. 2011, Pubmed
Fang, In vivo tumor targeting of tumor necrosis factor-alpha-loaded stealth nanoparticles: effect of MePEG molecular weight and particle size. 2006, Pubmed
Fujita, Toxicities of Receptor Tyrosine Kinase Inhibitors in Cancer Pharmacotherapy: Management with Clinical Pharmacology. 2017, Pubmed
Gaucher, Effect of poly(N-vinyl-pyrrolidone)-block-poly(D,L-lactide) as coating agent on the opsonization, phagocytosis, and pharmacokinetics of biodegradable nanoparticles. 2009, Pubmed
Gore, Pancreatic cancer stroma: friend or foe? 2014, Pubmed
Greish, Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines. 2007, Pubmed
Gunawan, Nanoparticle-protein corona complexes govern the biological fates and functions of nanoparticles. 2014, Pubmed
Hagendoorn, Onset of abnormal blood and lymphatic vessel function and interstitial hypertension in early stages of carcinogenesis. 2006, Pubmed
Hayashi, The role of surgery in the treatment of metastatic bone tumor. 2022, Pubmed
Heldin, High interstitial fluid pressure - an obstacle in cancer therapy. 2004, Pubmed
Helmlinger, Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. 1997, Pubmed
Hench, The story of Bioglass. 2006, Pubmed
Hodi, Improved survival with ipilimumab in patients with metastatic melanoma. 2010, Pubmed
Hoppe, A review of the biological response to ionic dissolution products from bioactive glasses and glass-ceramics. 2011, Pubmed
Hu, Quercetin Remodels the Tumor Microenvironment To Improve the Permeation, Retention, and Antitumor Effects of Nanoparticles. 2017, Pubmed
Hu, Design and evaluation a kind of functional biomaterial for bone tissue engineering: Selenium/mesoporous bioactive glass nanospheres. 2020, Pubmed
Huang, Electrospinning preparation and drug delivery properties of Eu3+/Tb3+ doped mesoporous bioactive glass nanofibers. 2012, Pubmed
Huo, Recent Advances in Nanostrategies Capable of Overcoming Biological Barriers for Tumor Management. 2020, Pubmed
Jain, Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers. 2013, Pubmed
Janmey, Mechanisms of mechanical signaling in development and disease. 2011, Pubmed
Johnstone, Surface-associated serum proteins inhibit the uptake of phosphatidylserine and poly(ethylene glycol) liposomes by mouse macrophages. 2001, Pubmed
Joyce, Microenvironmental regulation of metastasis. 2009, Pubmed
Kalluri, Basement membranes: structure, assembly and role in tumour angiogenesis. 2003, Pubmed
Kalluri, The biology and function of fibroblasts in cancer. 2016, Pubmed
Kaplon, Antibodies to watch in 2020. 2020, Pubmed
Kayki-Mutlu, A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2021. 2022, Pubmed
Kearns, Gene therapy companies have an ethical obligation to develop expanded access policies. 2021, Pubmed
Khalifehzadeh, Biodegradable calcium phosphate nanoparticles for cancer therapy. 2020, Pubmed
Kilcup, Stimulation of apoptotic pathways in liver cancer cells: An alternative perspective on the biocompatibility and the utility of biomedical glasses. 2016, Pubmed
Kokubo, How useful is SBF in predicting in vivo bone bioactivity? 2006, Pubmed
Kuhn, Proteolytic surface functionalization enhances in vitro magnetic nanoparticle mobility through extracellular matrix. 2006, Pubmed
Köhler, Continuous cultures of fused cells secreting antibody of predefined specificity. 1975, Pubmed
Le Pape, The role of osteoclasts in breast cancer bone metastasis. 2016, Pubmed
Leach, Enhancement of antitumor immunity by CTLA-4 blockade. 1996, Pubmed
Lee, Molecular targeted therapy: Treating cancer with specificity. 2018, Pubmed
Lheureux, Molecularly targeted therapies in cancer: a guide for the nuclear medicine physician. 2017, Pubmed
Li, CST6 protein and peptides inhibit breast cancer bone metastasis by suppressing CTSB activity and osteoclastogenesis. 2021, Pubmed
Li, Bio-inspired bioactive glasses for efficient microRNA and drug delivery. 2017, Pubmed
Lodish, Clinical review: kinase inhibitors: adverse effects related to the endocrine system. 2013, Pubmed
Maeda, Tumoritropic and lymphotropic principles of macromolecular drugs. 1989, Pubmed
Maeda, Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity. 2015, Pubmed
Maeda, A lipophilic derivative of neocarzinostatin. A polymer conjugation of an antitumor protein antibiotic. 1979, Pubmed
Maeda, Polymer therapeutics and the EPR effect. 2017, Pubmed
Mahoney, Clinical screening for breast cancer. 1982, Pubmed
Martin, Normalizing Function of Tumor Vessels: Progress, Opportunities, and Challenges. 2019, Pubmed
Matsumura, A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. 1986, Pubmed
McMillin, Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity. 2010, Pubmed
McMillin, The role of tumour-stromal interactions in modifying drug response: challenges and opportunities. 2013, Pubmed
Meng, Two-wave nanotherapy to target the stroma and optimize gemcitabine delivery to a human pancreatic cancer model in mice. 2013, Pubmed
Mikhail, Image-based analysis of the size- and time-dependent penetration of polymeric micelles in multicellular tumor spheroids and tumor xenografts. 2014, Pubmed
Mohammadi, Mechanisms and impact of altered tumour mechanics. 2018, Pubmed
Morais, Samarium doped glass-reinforced hydroxyapatite with enhanced osteoblastic performance and antibacterial properties for bone tissue regeneration. 2014, Pubmed
Motzer, Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma. 2015, Pubmed
Nagamitsu, Elevating blood pressure as a strategy to increase tumor-targeted delivery of macromolecular drug SMANCS: cases of advanced solid tumors. 2009, Pubmed
Ni Chonghaile, Pretreatment mitochondrial priming correlates with clinical response to cytotoxic chemotherapy. 2011, Pubmed
Nichols, Nano-sized drug carriers: Extravasation, intratumoral distribution, and their modeling. 2017, Pubmed
Oldenborg, Role of CD47 as a marker of self on red blood cells. 2000, Pubmed
Oliveira, Calcium Phosphate-Based Bioceramics in the Treatment of Osteosarcoma: Drug Delivery Composites and Magnetic Hyperthermia Agents. 2021, Pubmed
Overchuk, Overcoming obstacles in the tumor microenvironment: Recent advancements in nanoparticle delivery for cancer theranostics. 2018, Pubmed
Owens, Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. 2006, Pubmed
Palmerini, Rare Primary Malignant Bone Sarcomas. 2020, Pubmed
Pantulap, Bioactive glasses incorporating less-common ions to improve biological and physical properties. 2021, Pubmed
Peters, Antibody-drug conjugates as novel anti-cancer chemotherapeutics. 2015, Pubmed
Pillay, Antibodies in oncology. 2011, Pubmed
Polo, Molecular gates in mesoporous bioactive glasses for the treatment of bone tumors and infection. 2017, Pubmed
Pozzi, Effect of polyethyleneglycol (PEG) chain length on the bio-nano-interactions between PEGylated lipid nanoparticles and biological fluids: from nanostructure to uptake in cancer cells. 2014, Pubmed
Rodriguez, Minimal "Self" peptides that inhibit phagocytic clearance and enhance delivery of nanoparticles. 2013, Pubmed
Shao, Molecular understanding and design of zwitterionic materials. 2015, Pubmed
Sherman, Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy. 2014, Pubmed
Shoaib, Mesoporous nano-bioglass designed for the release of imatinib and in vitro inhibitory effects on cancer cells. 2017, Pubmed
Skalak, Compatibility and the genesis of residual stress by volumetric growth. 1996, Pubmed
Srisubut, Effect of local delivery of alendronate on bone formation in bioactive glass grafting in rats. 2007, Pubmed
Steiner, Antibody-radionuclide conjugates for cancer therapy: historical considerations and new trends. 2011, Pubmed
Stylianopoulos, Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors. 2012, Pubmed
Sui, Dual-Functional Dendritic Mesoporous Bioactive Glass Nanospheres for Calcium Influx-Mediated Specific Tumor Suppression and Controlled Drug Delivery in Vivo. 2018, Pubmed
Taurin, Anticancer nanomedicine and tumor vascular permeability; Where is the missing link? 2012, Pubmed
Tong, Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors. 2004, Pubmed
Tonigold, Pre-adsorption of antibodies enables targeting of nanocarriers despite a biomolecular corona. 2018, Pubmed
Torosean, Nanoparticle uptake in tumors is mediated by the interplay of vascular and collagen density with interstitial pressure. 2013, Pubmed
Tsai, Platelet adhesion to radiofrequency glow-discharge-deposited fluorocarbon polymers preadsorbed with selectively depleted plasmas show the primary role of fibrinogen. 2004, Pubmed
Tsimberidou, Targeted therapy in cancer. 2015, Pubmed
Tsumoto, Future perspectives of therapeutic monoclonal antibodies. 2019, Pubmed
Vonarbourg, Evaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptake. 2006, Pubmed
Välimäki, Effect of zoledronic acid on incorporation of a bioceramic bone graft substitute. 2006, Pubmed
Wagner, Chemotherapy for Bone Sarcoma in Adults. 2016, Pubmed
Wang, Novel targeted drugs approved by the NMPA and FDA in 2019. 2020, Pubmed
Wang, Sol-gel derived terbium-containing mesoporous bioactive glasses nanospheres: In vitro hydroxyapatite formation and drug delivery. 2017, Pubmed
Weber, Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial. 2015, Pubmed
Weiner, Monoclonal antibodies: versatile platforms for cancer immunotherapy. 2010, Pubmed
Westhauser, Selective and caspase-independent cytotoxicity of bioactive glasses towards giant cell tumor of bone derived neoplastic stromal cells but not to bone marrow derived stromal cells. 2021, Pubmed
Yamaoka, Receptor Tyrosine Kinase-Targeted Cancer Therapy. 2018, Pubmed
Younes, Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas. 2010, Pubmed
Yu, Intrinsic Ultrahigh Drug/miRNA Loading Capacity of Biodegradable Bioactive Glass Nanoparticles toward Highly Efficient Pharmaceutical Delivery. 2017, Pubmed
Zahavi, Monoclonal Antibodies in Cancer Therapy. 2020, Pubmed
Zambanini, Holmium-Containing Bioactive Glasses Dispersed in Poloxamer 407 Hydrogel as a Theragenerative Composite for Bone Cancer Treatment. 2021, Pubmed
Zhang, Anti-PEG antibodies in the clinic: Current issues and beyond PEGylation. 2016, Pubmed
Zhang, 3D-printed magnetic Fe3O4/MBG/PCL composite scaffolds with multifunctionality of bone regeneration, local anticancer drug delivery and hyperthermia. 2014, Pubmed
Zhang, Design and Evaluation of Europium Containing Mesoporous Bioactive Glass Nanospheres: Doxorubicin Release Kinetics and Inhibitory Effect on Osteosarcoma MG 63 Cells. 2018, Pubmed
Zhang, A doxorubicin delivery system: Samarium/mesoporous bioactive glass/alginate composite microspheres. 2016, Pubmed
Zhang, Construction of tellurium-doped mesoporous bioactive glass nanoparticles for bone cancer therapy by promoting ROS-mediated apoptosis and antibacterial activity. 2022, Pubmed
Zhou, Hyaluronidase Embedded in Nanocarrier PEG Shell for Enhanced Tumor Penetration and Highly Efficient Antitumor Efficacy. 2016, Pubmed
Zhou, Enzyme-activatable polymer-drug conjugate augments tumour penetration and treatment efficacy. 2019, Pubmed